DSC Advisors, L.P.
- SEC CIK
- 0001299434
- Latest filing
- Nov 14, 2024
YARW holding history
Yarrow Bioscience, Inc. in every 13F filed by DSC Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
YARW overviewAll 13F holders of YARWFull Q3 2024 holdings
- Shares (Q3 2024)
- 696,465
- Value
- $1.31M
- % of portfolio
- 11.9%
- Quarters held
- 15
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 696,465 | $1.31M | 11.9% | 00.0% | Unchanged | Holders |
| Q2 2024 | 696,465 | $1.37M | 4.6% | 00.0% | Unchanged | Holders |
| Q1 2024 | 696,465 | $2.14M | 3.5% | 00.0% | Unchanged | Holders |
| Q4 2023 | 696,465 | $1.62M | 2.8% | +581,465+505.6% | Added | Holders |
| Q3 2023 | 115,000 | $460.0K | 0.7% | 00.0% | Unchanged | Holders |
| Q2 2023 | 115,000 | $466.9K | 0.7% | 00.0% | Unchanged | Holders |
| Q1 2023 | 115,000 | $354.2K | 0.7% | +27,778+31.8% | AddedConverted for a 1-for-18 split | Holders |
| Q4 2022 | 1,570,000 | $235.5K | 0.5% | −1,100,000−41.2% | Reduced | Holders |
| Q3 2022 | 2,670,000 | $596.0K | 0.6% | 00.0% | Unchanged | Holders |
| Q2 2022 | 2,670,000 | $1.04M | 1.0% | 00.0% | Unchanged | Holders |
| Q1 2022 | 2,670,000 | $1.74M | 1.4% | +119,000+4.7% | Added | Holders |
| Q4 2021 | 2,551,000 | $2.60M | 3.0% | +1,451,000+131.9% | Added | Holders |
| Q3 2021 | 1,100,000 | $1.53M | 2.0% | 00.0% | Unchanged | Holders |
| Q2 2021 | 1,100,000 | $3.86M | 3.7% | +61,855+6.0% | Added | Holders |
| Q1 2021 | 1,038,145 | $7.11M | 5.8% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.